Thomas Stephen Basil bought CLYM
January 1, 2025 · Form 4 insider transaction
Thomas Stephen Basil bought 50,188 shares of Climb Bio Inc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,188
Price
N/A
Total value
N/A
InsiderThomas Stephen Basil
RoleDirector
CompanyClimb Bio Inc (CLYM)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 1, 2025
Filing dateJanuary 3, 2025
Shares owned after154,095
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.